Total Raised

$25.37M

Investors Count

8

Deal Terms

1

Funding, Valuation & Revenue

6 Fundings

Aiforia has raised $25.37M over 6 rounds.

Aiforia's latest funding round was a IPO for on December 10, 2021.

Aiforia's 2021 revenue was $1.13M. Aiforia's most recent revenue is from 2021.

Sign up for a free demo to see revenue data from 2021 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/10/2021

IPO

$XXM

$X.XXB

((X.XXx))

FY XXXX

1

6/3/2021

Series B

$XXM

$XXM

$1.13M

FY 2021

10

3/5/2020

Incubator/Accelerator

$XXM

$X.XXB

((X.XXx))

FY XXXX

10

11/18/2019

Grant

$XXM

$XXM

0

FY undefined

10

12/1/2017

Series A

$XXM

$XXM

0

FY undefined

10

Date

12/10/2021

6/3/2021

3/5/2020

11/18/2019

12/1/2017

Round

IPO

Series B

Incubator/Accelerator

Grant

Series A

Amount

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

$X.XXB

((X.XXx))

FY XXXX

$1.13M

FY 2021

$X.XXB

((X.XXx))

FY XXXX

0

FY undefined

0

FY undefined

Sources

1

10

10

10

10

Start free trial
New call-to-action

Aiforia Deal Terms

1 Deal Term

Aiforia's deal structure is available for 1 funding round, including their Series A from December 01, 2017.

Round

Series A

Funding Date

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$XXM

$XXM

$XXM

$XXM

Aiforia Investors

8 Investors

Aiforia has 8 investors. PHC Holdings invested in Aiforia's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/3/2021

6/3/2021

1
Series B

Corporation

Japan

00/00/0000

00/00/0000

Aktia Bank

Subscribe to see more

Bank

Finland

00/00/0000

00/00/0000

NVIDIA Inception Program

Subscribe to see more

Incubator/Accelerator

California

00/00/0000

00/00/0000

Horizon 2020

Subscribe to see more

Government

Belgium

00/00/0000

00/00/0000

Ascend Capital Partners

Subscribe to see more

Venture Capital

Hong Kong

First funding

6/3/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

6/3/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Aktia Bank

NVIDIA Inception Program

Horizon 2020

Ascend Capital Partners

Rounds

1
Series B

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Bank

Incubator/Accelerator

Government

Venture Capital

Location

Japan

Finland

California

Belgium

Hong Kong

New call-to-action

Compare Aiforia to Competitors

AIRA Matrix Logo
AIRA Matrix

AIRA Matrix provides artificial intelligence solutions for the healthcare and life sciences sectors, offering digital pathology as a service, custom AI development, and tools for drug discovery, preclinical research, and clinical applications. The focus is on enhancing efficiency, diagnostic accuracy, and turnaround times in pathology laboratory workflows, as well as supporting disease stratification and management in cancer care. It was founded in 2011 and is based in Mumbai, India.

PathAI Logo
PathAI

PathAI provides artificial intelligence (AI)-powered research tools and services for pathology. It delivers the diagnosis and treatment of cancer by leveraging modern approaches in machine learning. The company offers biopharmacy lab services, clinical development services, drug and diagnostic development, and more. It was founded in 2016 and is based in Boston, Massachusetts.

Mindpeak Logo
Mindpeak

Mindpeak specializes in artificial intelligence for clinical pathology within the healthcare sector. The company offers diagnostic software that aids in clinical pathology and provides analysis of tissue samples. Mindpeak's products are used in pathology labs and clinical research. It was founded in 2018 and is based in Hamburg, Germany.

Ibex Logo
Ibex

Ibex focuses on AI-based cancer diagnostics within the healthcare sector, particularly in pathology. The company provides diagnostic solutions that assist pathologists in detecting cancer and other features in tissue samples, with the objective of supporting the accuracy and efficiency of cancer diagnosis. Ibex serves the healthcare and medical diagnostics industry, with attention to the workflow and capabilities of pathologists. It was founded in 2016 and is based in Tel Aviv, Israel.

A
Aiosyn

Aiosyn focuses on developing precision pathology software solutions for the healthcare sector. The company offers AI-powered algorithms that enhance digital pathology workflows and support clinical diagnostics, as well as tools for the identification of pathology-based biomarkers for drug development. Aiosyn primarily serves the healthcare industry, including pathology laboratories and biopharmaceutical companies. It was founded in 2021 and is based in Nijmegen, Netherlands.

A
Azra AI

Azra AI focuses on healthcare technology with an emphasis on automating oncology workflows. The company provides artificial intelligence (AI) solutions that identify cancer diagnoses and incidental findings in real-time, automate cancer registry processes, and facilitate tumor board case management. The platform aims to enhance patient care management, offer reporting and analytics, and provide clinical consulting services, serving the healthcare and oncology sectors. Azra AI was formerly known as Invenero Holdings. It was founded in 2022 and is based in Nashville, Tennessee.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.